Profil
Thomas Schäfer is currently a Director at Bioinnovation Institute and BacThera AG.
He was previously the Head of Business Development at Novozymes A. From 2017 to 2022, he served as the Chief Scientific Officer and Executive VP at Chr.
Hansen Holding A. Schäfer holds a doctorate degree from Freie Universität Berlin.
Dernières actualités sur Thomas Schäfer
Postes actifs de Thomas Schäfer
| Sociétés | Poste | Début |
|---|---|---|
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Directeur/Membre du Conseil | - |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Schäfer
| Sociétés | Poste | Fin |
|---|---|---|
| CHRISTIAN HANSEN | Directeur Technique/Scientifique/R&D | 31/03/2022 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
Formation de Thomas Schäfer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Health Technology |
















